The function of embryonic stem cell-expressed RAS (E-RAS), a unique RAS family member, correlates with its additional motifs and its structural properties

Journal of Biological Chemistry

Volumn 290, Issue 25, 2015, Pages 15892-15903

  Nakhaei Rad, Saeideh ^a   Nakhaeizadeh, Hossein ^a   Kordes, Claus ^a   Cirstea, Ion C ^a,b   Schmick, Malte ^c   Dvorsky, Radovan ^a   Bastiaens, Philippe I H ^c   Häussinger, Dieter ^a   Ahmadian, Mohammad Reza ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL GROWTH; PROTEINS;

EFFECTOR BINDING; EMBRYONIC STEM CELLS; GASTRIC TUMORS; HEPATIC STELLATE CELLS; MOLECULAR MECHANISM; N-TERMINAL EXTENSION; SIGNALING ACTIVITY; STRUCTURAL FEATURE;

STEM CELLS;

EMBRYONIC STEM CELL EXPRESSED RAS PROTEIN; RAS PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG; ERAS PROTEIN, HUMAN; HRAS PROTEIN, HUMAN; PROTEIN P21;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DOG; GENETICS; MDCK CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY;

AMINO ACID MOTIFS; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DOGS; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; ONCOGENE PROTEIN P21(RAS); PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS P21(RAS); SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 84940093426     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.640607     Document Type: Article

References (82)

1. Vetter, I. R. (2001) The guanine nucleotide-binding switch in three dimensions. Science 294, 1299-1304
2. Boguski, M. S., and McCormick, F. (1993) Proteins regulating Ras and its relatives. Nature 366, 643-654
3. Ahmadian, M. R., Wittinghofer, A., and Schmidt, G. (2002) The actin filament architecture: tightly regulated by the cells, manipulated by pathogens. International Titisee Conference on the actin cytoskeleton: from signalling to bacterial pathogenesis. EMBO Rep. 3, 214-218
4. Gremer, L., Merbitz-Zahradnik, T., Dvorsky, R., Cirstea, I. C., Kratz, C. P., Zenker, M., Wittinghofer, A., and Ahmadian, M. R. (2011) Germ line KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders. Hum. Mutat. 32, 33-43
5. Karnoub, A. E., and Weinberg, R. A. (2008) Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9, 517-531
6. Pylayeva-Gupta, Y., Grabocka, E., and Bar-Sagi, D. (2011) RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11, 761-774
7. Tidyman, W. E., and Rauen, K. A. (2009) The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr. Opin. Genet. Dev. 19, 230-236
8. Flex, E., Jaiswal, M., Pantaleoni, F., Martinelli, S., Strullu, M., Fansa, E. K., Caye, A., De Luca, A., Lepri, F., Dvorsky, R., Pannone, L., Paolacci, S., Zhang, S. C., Fodale, V., Bocchinfuso, G., et al. (2014) Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. Hum. Mol. Genet. 23, 4315-4327
9. Cirstea, I. C., Gremer, L., Dvorsky, R., Zhang, S. C., Piekorz, R. P., Zenker, M., and Ahmadian, M. R. (2013) Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-faciocutaneous syndromes. Hum. Mol. Genet. 22, 262-270
10. Castellano, E., and Santos, E. (2011) Functional specificity of Ras isoforms: so similar but so different. Genes Cancer 2, 216-231
11. Ichise, T., Yoshida, N., and Ichise, H. (2010) H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice. Development 137, 1003-1013
12. Omerovic, J., Laude, A. J., and Prior, I. A. (2007) Ras proteins: paradigms for compartmentalised and isoform-specific signalling. Cell. Mol. Life Sci. 64, 2575-2589
13. Potenza, N., Vecchione, C., Notte, A., De Rienzo, A., Rosica, A., Bauer, L., Affuso, A., De Felice, M., Russo, T., Poulet, R., Cifelli, G., De Vita, G., Lembo, G., and Di Lauro, R. (2005) Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep. 6, 432-437
14. Leon, J., Guerrero, I., and Pellicer, A. (1987) Differential expression of the ras gene family in mice. Mol. Cell. Biol. 7, 1535-1540
15. Johnson, L., Greenbaum, D., Cichowski, K., Mercer, K., Murphy, E., Schmitt, E., Bronson, R. T., Umanoff, H., Edelmann, W., Kucherlapati, R., and Jacks, T. (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11, 2468-2481
16. Nakamura, K., Ichise, H., Nakao, K., Hatta, T., Otani, H., Sakagami, H., Kondo, H., and Katsuki, M. (2008) Partial functional overlap of the three ras genes in mouse embryonic development. Oncogene 27, 2961-2968
17. Lau, K. S., and Haigis, K. M. (2009) Nonredundancy within the RAS oncogene family: insights into mutational disparities in cancer. Mol. Cells 28, 315-320
18. Takahashi, K., Mitsui, K., and Yamanaka, S. (2003) Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423, 541-545
19. Tanaka, Y., Ikeda, T., Kishi, Y., Masuda, S., Shibata, H., Takeuchi, K., Komura, M., Iwanaka, T., Muramatsu, S., Kondo, Y., Takahashi, K., Yamanaka, S., and Hanazono, Y. (2009) ERas is expressed in primate embryonic stem cells but not related to tumorigenesis. Cell Transplant. 18, 381-389
20. Aoyama, M., Kataoka, H., Kubota, E., Tada, T., and Asai, K. (2010) Resistance to chemotherapeutic agents and promotion of transforming activity mediated by embryonic stem cell-expressed Ras (ERas) signal in neuroblastoma cells. Int. J. Oncol. 37, 1011-1016
21. Kubota, E., Kataoka, H., Aoyama, M., Mizoshita, T., Mori, Y., Shimura, T., Tanaka, M., Sasaki, M., Takahashi, S., Asai, K., and Joh, T. (2010) Role of ES cell-expressed Ras (ERas) in tumorigenicity of gastric cancer. Am. J. Pathol. 177, 955-963
22. Willumsen, B. M., Christensen, A., Hubbert, N. L., Papageorge, A. G., and Lowy, D. R. (1984) The p21 ras C-terminus is required for transformation and membrane association. Nature 310, 583-586
23. Ahearn, I. M., Haigis, K., Bar-Sagi, D., and Philips, M. R. (2012) Regulating the regulator: post-translational modification of RAS. Nat. Rev. Mol. Cell Biol. 13, 39-51
24. Schmick, M., Vartak, N., Papke, B., Kovacevic, M., Truxius, D. C., Rossmannek, L., and Bastiaens, P. I. (2014) KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport. Cell 157, 459-471
25. Rocks, O., Peyker, A., Kahms, M., Verveer, P. J., Koerner, C., Lumbierres, M., Kuhlmann, J., Waldmann, H., Wittinghofer, A., and Bastiaens, P. I. (2005) An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307, 1746-1752
26. Takahashi, K., Murakami, M., and Yamanaka, S. (2005) Role of the phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells. Biochem. Soc. Trans. 33, 1522-1525
27. Yu, Y., Liang, D., Tian, Q., Chen, X., Jiang, B., Chou, B.-K., Hu, P., Cheng, L., Gao, P., Li, J., and Wang, G. (2014) Stimulation of somatic cell reprogramming by ERas-Akt-FoxO1 signaling axis. Stem Cells 32, 349-363
28. Lerner, E. C., Qian, Y., Blaskovich, M. A., Fossum, R. D., Vogt, A., Sun, J., Cox, A. D., Der, C. J., Hamilton, A. D., and Sebti, S. M. (1995) Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem. 270, 26802-26806
29. Apolloni, A., Prior, I. A., Lindsay, M., Parton, R. G., and Hancock, J. F. (2000) H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol. Cell. Biol. 20, 2475-2487
30. Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., and Wittinghofer, A. (1997) The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277, 333-338
31. Ahmadian, M. R., Hoffmann, U., Goody, R. S., and Wittinghofer, A. (1997) Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry 36, 4535-4541
32. Ahmadian, M. R., Stege, P., Scheffzek, K., and Wittinghofer, A. (1997) Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat. Struct. Biol. 4, 686-689
33. Lenzen, C., Cool, R. H., Prinz, H., Kuhlmann, J., and Wittinghofer, A. (1998) Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm. Biochemistry 37, 7420-7430
34. Buday, L., and Downward, J. (2008) Many faces of Ras activation. Biochim. Biophys. Acta 1786, 178-187
35. Bourne, H. R., Sanders, D. A., and McCormick, F. (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348, 125-132
36. Bourne, H. R., Sanders, D. A., and McCormick, F. (1991) The GTPase superfamily: conserved structure and molecular mechanism. Nature 349, 117-127
37. Saraste, M., Sibbald, P. R., and Wittinghofer, A. (1990) The P-loop-a common motif in ATP- and GTP-binding proteins. Trends Biochem. Sci. 15, 430-434
38. Bos, J. L. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689
39. Herrmann, C. (2003) Ras-effector interactions: after one decade. Curr. Opin. Struct. Biol. 13, 122-129
40. Schmidt, G., Lenzen, C., Simon, I., Deuter, R., Cool, R. H., Goody, R. S., and Wittinghofer, A. (1996) Biochemical and biological consequences of changing the specificity of p21ras from guanosine to xanthosine nucleotides. Oncogene 12, 87-96
41. Wittinghofer, A., and Vetter, I. R. (2011) Structure-function relationships of the G domain, a canonical switch motif. Annu. Rev. Biochem. 80, 943-971
42. Takahashi, K., Nakagawa, M., Young, S. G., and Yamanaka, S. (2005) Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase/mTOR pathway. J. Biol. Chem. 280, 32768-32774
43. Tucker, J., Sczakiel, G., Feuerstein, J., John, J., Goody, R. S., and Wittinghofer, A. (1986) Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J. 5, 1351-1358
44. Cirstea, I. C., Kutsche, K., Dvorsky, R., Gremer, L., Carta, C., Horn, D., Roberts, A. E., Lepri, F., Merbitz-Zahradnik, T., König, R., Kratz, C. P., Pantaleoni, F., Dentici, M. L., Joshi, V. A., Kucherlapati, R. S., et al. (2010) A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat. Genet. 42, 27-29
45. Margarit, S. M., Sondermann, H., Hall, B. E., Nagar, B., Hoelz, A., Pirruccello, M., Bar-Sagi, D., and Kuriyan, J. (2003) Structural evidence for feedback activation by Ras. GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112, 685-695
46. Nassar, N., Horn, G., Herrmann, C., Block, C., Janknecht, R., and Wittinghofer, A. (1996) Ras/Rap effector specificity determined by charge reversal. Nat. Struct. Biol. 3, 723-729
47. Filchtinski, D., Sharabi, O., Rüppel, A., Vetter, I. R., Herrmann, C., and Shifman, J. M. (2010) What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf. J. Mol. Biol. 399, 422-435
48. Pacold, M. E., Suire, S., Perisic, O., Lara-Gonzalez, S., Davis, C. T., Walker, E. H., Hawkins, P. T., Stephens, L., Eccleston, J. F., and Williams, R. L. (2000) Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase γ. Cell 103, 931-943
49. Scheffzek, K., Grünewald, P., Wohlgemuth, S., Kabsch, W., Tu, H., Wigler, M., Wittinghofer, A., and Herrmann, C. (2001) The Ras-Byr2RBD complex: structural basis for Ras effector recognition in yeast. Structure 9, 1043-1050
50. Huang, L., Hofer, F., Martin, G. S., and Kim, S. H. (1998) Structural basis for the interaction of Ras with RalGDS. Nat. Struct. Biol. 5, 422-426
51. Bunney, T. D., Harris, R., Gandarillas, N. L., Josephs, M. B., Roe, S. M., Sorli, S. C., Paterson, H. F., Rodrigues-Lima, F., Esposito, D., Ponting, C. P., Gierschik, P., Pearl, L. H., Driscoll, P. C., and Katan, M. (2006) Structural and mechanistic insights into ras association domains of phospholipase Cε. Mol. Cell 21, 495-507
52. Qamra, R., and Hubbard, S. R. (2013) Structural basis for the interaction of the adaptor protein grb14 with activated ras. PLoS One 8, e72473
53. Stieglitz, B., Bee, C., Schwarz, D., Yildiz, O., Moshnikova, A., Khokhlatchev, A., and Herrmann, C. (2008) Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II. EMBO J. 27, 1995-2005
54. Vavvas, D., Li, X., Avruch, J., and Zhang, X. F. (1998) Identification of Nore1 as a potential Ras effector. J. Biol. Chem. 273, 5439-5442
55. González-García, A., Pritchard, C. A., Paterson, H. F., Mavria, G., Stamp, G., and Marshall, C. J. (2005) RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7, 219-226
56. Castellano, E., and Downward, J. (2011) RAS interaction with PI3K: more than just another effector pathway. Genes Cancer 2, 261-274
57. Bunney, T. D., and Katan, M. (2006) Phospholipase Cε: linking second messengers and small GTPases. Trends Cell Biol. 16, 640-648
58. Yan, J., Roy, S., Apolloni, A., Lane, A., and Hancock, J. F. (1998) Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273, 24052-24056
59. Song, C., Hu, C. D., Masago, M., Kariyai, K., Yamawaki-Kataoka, Y., Shibatohge, M., Wu, D., Satoh, T., and Kataoka, T. (2001) Regulation of a novel human phospholipase C, PLC, through membrane targeting by Ras. J. Biol. Chem. 276, 2752-2757
60. Kuriyama, M., Harada, N., Kuroda, S., Yamamoto, T., Nakafuku, M., Iwamatsu, A., Yamamoto, D., Prasad, R., Croce, C., Canaani, E., and Kaibuchi, K. (1996) Identification of AF-6 and canoe as putative targets for Ras. J. Biol. Chem. 271, 607-610
61. Lambert, J. M., Lambert, Q. T., Reuther, G. W., Malliri, A., Siderovski, D. P., Sondek, J., Collard, J. G., and Der, C. J. (2002) Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat. Cell Biol. 4, 621-625
62. Hancock, J. F., Magee, A. I., Childs, J. E., and Marshall, C. J. (1989) All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57, 1167-1177
63. Matallanas, D., Sanz-Moreno, V., Arozarena, I., Calvo, F., Agudo-Ibáñez, L., Santos, E., Berciano, M. T., and Crespo, P. (2006) Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol. Cell. Biol. 26, 100-116
64. Goodwin, J. S., Drake, K. R., Rogers, C., Wright, L., Lippincott-Schwartz, J., Philips, M. R., and Kenworthy, A. K. (2005) Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. J. Cell Biol. 170, 261-272
65. Kaizaki, R., Yashiro, M., Shinto, O., Yasuda, K., Matsuzaki, T., Sawada, T., and Hirakawa, K. (2009) Expression of ERas oncogene in gastric carcinoma. Anticancer Res. 29, 2189-2193
66. Simons, K., and Toomre, D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31-39
67. Iwabuchi, K., Handa, K., and Hakomori, S. (1998) Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J. Biol. Chem. 273, 33766-33773
68. Jaumot, M., Yan, J., Clyde-Smith, J., Sluimer, J., and Hancock, J. F. (2002) The linker domain of the Ha-Ras hypervariable region regulates interactions with exchange factors, Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 277, 272-278
69. Prior, I. A., Muncke, C., Parton, R. G., and Hancock, J. F. (2003) Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J. Cell Biol. 160, 165-170
70. Prior, I. A., and Hancock, J. F. (2001) Compartmentalization of Ras proteins. J. Cell Sci. 114, 1603-1608
71. Rotblat, B., Prior, I. A., Muncke, C., Parton, R. G., Kloog, Y., Henis, Y. I., and Hancock, J. F. (2004) Three separable domains regulate GTP-dependent association of H-ras with the plasma membrane. Mol. Cell. Biol. 24, 6799-6810
72. Innocenti, M., Frittoli, E., Ponzanelli, I., Falck, J. R., Brachmann, S. M., Di Fiore, P. P., and Scita, G. (2003) Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J. Cell Biol. 160, 17-23
73. Inabe, K., Ishiai, M., Scharenberg, A. M., Freshney, N., Downward, J., and Kurosaki, T. (2002) Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195, 189-200
74. Dillon, L. M., Bean, J. R., Yang, W., Shee, K., Symonds, L. K., Balko, J. M., McDonald, W. H., Liu, S., Gonzalez-Angulo, A. M., Mills, G. B., Arteaga, C. L., and Miller, T. W. (2014) P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer. Oncogene 6, 328
75. Holly, S. P., Larson, M. K., and Parise, L. V. (2005) The unique N-terminus of R-ras is required for Rac activation and precise regulation of cell migration. Mol. Biol. Cell 16, 2458-2469
76. Riou, P., Kjær, S., Garg, R., Purkiss, A., George, R., Cain, R. J., Bineva, G., Reymond, N., McColl, B., Thompson, A. J., O'Reilly, N., McDonald, N. Q., Parker, P. J., and Ridley, A. J. (2013) 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. Cell 153, 640-653
77. Jaiswal, M., Dvorsky, R., and Ahmadian, M. R. (2013) Deciphering the molecular and functional basis of Dbl family proteins: a novel systematic approach toward classification of selective activation of the Rho family proteins. J. Biol. Chem. 288, 4486-4500
78. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., and Bilanges, B. (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell Biol. 11, 329-341
79. Matsunaga-Udagawa, R., Fujita, Y., Yoshiki, S., Terai, K., Kamioka, Y., Kiyokawa, E., Yugi, K., Aoki, K., and Matsuda, M. (2010) The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf. J. Biol. Chem. 285, 7818-7826
80. Cordeddu, V., Di Schiavi, E., Pennacchio, L. A., Ma'ayan, A., Sarkozy, A., Fodale, V., Cecchetti, S., Cardinale, A., Martin, J., Schackwitz, W., Lipzen, A., Zampino, G., Mazzanti, L., Digilio, M. C., Martinelli, S., et al. (2009) Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat. Genet. 41, 1022-1026
81. Rodriguez-Viciana, P., Oses-Prieto, J., Burlingame, A., Fried, M., and McCormick, F. (2006) A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol. Cell 22, 217-230
82. Ferro, E., and Trabalzini, L. (2010) RalGDS family members couple Ras to Ral signalling and that's not all. Cell. Signal. 22, 1804-1810